Brittle cornea syndrome: current perspectives [Response to Letter]

Andrew Walkden,1,2 Emma Burkitt-Wright,3,4 Leon Au1,2 1Manchester Royal Eye Hospital, Manchester University Foundation Trust, Manchester, UK; 2Medical Academic Health Sciences Centre, University of Manchester, UK; 3Genetic Medicine, Institute of Human Development, Faculty of Medical and Human Scienc...

Full description

Bibliographic Details
Main Authors: Walkden A, Burkitt-Wright E, Au L
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Clinical Ophthalmology
Online Access:https://www.dovepress.com/brittle-cornea-syndrome-current-perspectives-response-to-letter-peer-reviewed-article-OPTH
id doaj-ed630e5cbf754788a4bdd16b1c4d293b
record_format Article
spelling doaj-ed630e5cbf754788a4bdd16b1c4d293b2020-11-24T21:48:58ZengDove Medical PressClinical Ophthalmology1177-54832019-09-01Volume 131895189648813Brittle cornea syndrome: current perspectives [Response to Letter]Walkden ABurkitt-Wright EAu LAndrew Walkden,1,2 Emma Burkitt-Wright,3,4 Leon Au1,2 1Manchester Royal Eye Hospital, Manchester University Foundation Trust, Manchester, UK; 2Medical Academic Health Sciences Centre, University of Manchester, UK; 3Genetic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK; 4Genetic Medicine, St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UKCorrespondence: Andrew WalkdenManchester Royal Eye Hospital, Manchester University Foundation Trust, Oxford Road, Manchester M13 9WL, UK, Tel +44 779 215 3269Email walkdenandrew@gmail.com We would like to thank Srirampur and colleagues for their comments with regards to our review article on Brittle Cornea Syndrome, and we are delighted to learn that they agree with our approach to managing a rare, complex and devastating condition.We thank them for highlighting the difficulties associated with suturing such thin and friable corneal tissue, and this issue has been touched upon by other colleagues within the literature.1–3 Your comments on post operative management in terms of suture rotation and steroid titration are interesting and well thought out, and the aim of increasing stromal collagen deposition and more effective healing should be encouraged. We will certainly apply these principles in future cases.We commend our colleagues from Hyderabad, India for their valuable comments and we would welcome any further thoughts from other colleagues around the world that have had the opportunity to manage such a rare and challenging condition.This is in response to the Letter to the EditorView the original paper by Walkden and colleagueshttps://www.dovepress.com/brittle-cornea-syndrome-current-perspectives-response-to-letter-peer-reviewed-article-OPTH
collection DOAJ
language English
format Article
sources DOAJ
author Walkden A
Burkitt-Wright E
Au L
spellingShingle Walkden A
Burkitt-Wright E
Au L
Brittle cornea syndrome: current perspectives [Response to Letter]
Clinical Ophthalmology
author_facet Walkden A
Burkitt-Wright E
Au L
author_sort Walkden A
title Brittle cornea syndrome: current perspectives [Response to Letter]
title_short Brittle cornea syndrome: current perspectives [Response to Letter]
title_full Brittle cornea syndrome: current perspectives [Response to Letter]
title_fullStr Brittle cornea syndrome: current perspectives [Response to Letter]
title_full_unstemmed Brittle cornea syndrome: current perspectives [Response to Letter]
title_sort brittle cornea syndrome: current perspectives [response to letter]
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5483
publishDate 2019-09-01
description Andrew Walkden,1,2 Emma Burkitt-Wright,3,4 Leon Au1,2 1Manchester Royal Eye Hospital, Manchester University Foundation Trust, Manchester, UK; 2Medical Academic Health Sciences Centre, University of Manchester, UK; 3Genetic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK; 4Genetic Medicine, St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UKCorrespondence: Andrew WalkdenManchester Royal Eye Hospital, Manchester University Foundation Trust, Oxford Road, Manchester M13 9WL, UK, Tel +44 779 215 3269Email walkdenandrew@gmail.com We would like to thank Srirampur and colleagues for their comments with regards to our review article on Brittle Cornea Syndrome, and we are delighted to learn that they agree with our approach to managing a rare, complex and devastating condition.We thank them for highlighting the difficulties associated with suturing such thin and friable corneal tissue, and this issue has been touched upon by other colleagues within the literature.1–3 Your comments on post operative management in terms of suture rotation and steroid titration are interesting and well thought out, and the aim of increasing stromal collagen deposition and more effective healing should be encouraged. We will certainly apply these principles in future cases.We commend our colleagues from Hyderabad, India for their valuable comments and we would welcome any further thoughts from other colleagues around the world that have had the opportunity to manage such a rare and challenging condition.This is in response to the Letter to the EditorView the original paper by Walkden and colleagues
url https://www.dovepress.com/brittle-cornea-syndrome-current-perspectives-response-to-letter-peer-reviewed-article-OPTH
work_keys_str_mv AT walkdena brittlecorneasyndromecurrentperspectivesresponsetoletter
AT burkittwrighte brittlecorneasyndromecurrentperspectivesresponsetoletter
AT aul brittlecorneasyndromecurrentperspectivesresponsetoletter
_version_ 1716644318258659329